Axogen Inc
(AXGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20 | 1,020 | 2,187 | 590 | 839 |
| Marketable Securities | 0 | 0 | 578 | 0 | 0 |
| Receivables | 1,960 | 2,710 | 2,342 | 2,278 | 2,416 |
| Inventories | 2,140 | 1,880 | 1,718 | 2,353 | 2,051 |
| Other current assets | 610 | 620 | -96 | 602 | 530 |
| TOTAL | $4,730 | $6,230 | $6,729 | $5,823 | $5,836 |
| Non-Current Assets | |||||
| PPE Net | 3,870 | 4,100 | 4,307 | 4,867 | 5,560 |
| Investments And Advances | 0 | 9 | 0 | 1,114 | 568 |
| Other Non-Current Assets | 175 | 250 | 0 | 451 | 755 |
| TOTAL | $4,045 | $4,359 | $4,307 | $6,432 | $6,883 |
| Total Assets | $8,780 | $10,590 | $11,318 | $12,255 | $12,719 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,670 | 1,470 | 0 | 736 | 771 |
| Accrued Expenses | 770 | 530 | N/A | 536 | 575 |
| TOTAL | $2,450 | $2,010 | $1,393 | $1,272 | $1,346 |
| Non-Current Liabilities | |||||
| TOTAL | $190 | $220 | $N/A | $174 | $167 |
| Total Liabilities | $2,640 | $2,230 | $2,839 | $1,446 | $1,513 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 40 | 38 | 38 |
| Retained earnings | -5,180 | -2,910 | N/A | 346 | 1,205 |
| Other shareholders' equity | 0 | 0 | 9,663 | 7,000 | -51 |
| TOTAL | $6,130 | $8,360 | $9,703 | $17,837 | $11,206 |
| Total Liabilities And Equity | $8,770 | $10,590 | $12,542 | $19,283 | $12,719 |